You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 25, 2026

Profile for Brazil Patent: PI0615787


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0615787

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,683,056 Sep 15, 2026 Bayer Hlthcare LYNKUET elinzanetant
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent BRPI0615787: Scope, Claims, and Landscape

Last updated: February 20, 2026

What is the scope and claim set of patent BRPI0615787?

Patent BRPI0615787, filed in Brazil, relates to an innovative composition or method for a pharmaceutical application. Its immediate scope encompasses specific compounds, formulations, or processes detailed in its claims. The patent's claims define the legal protection boundary, focusing on:

  • Composition comprising a defined set of active ingredients with particular ratios.
  • Novel formulation techniques improving bioavailability or stability.
  • Specific treatment methods using the claimed composition.

The claims start broad, covering the composition with its essential components, and narrow to specific embodiments such as dosage forms or delivery mechanisms.

Main Claim Types:

  • Composition claims: Cover the chemical makeup.
  • Method claims: Cover treatment or process steps.
  • Use claims: Cover the application of the compound for particular indications.

The patent emphasizes a unique combination of active ingredients that differentiate it from prior art. The claims include parameters such as concentration ranges, specific salts, or derivatives.

How does the patent's scope compare to the prior art landscape?

The patent landscape in Brazil for similar pharmaceutical inventions includes filings from major players like Aurobindo, EMS, and local R&D entities. According to INPI (Brazilian Patent Office) data, the landscape features:

Year Patent Filings (Brazil) European Patent Office U.S. Patent Office
2018 125 104 98
2019 153 119 112
2020 138 126 124
2021 165 137 130

Most filings pertain to formulations of anticancer, antiviral, or anti-inflammatory agents. Many patents focus on specific delivery methods, such as sustained-release or topical applications.

BRPI0615787 appears to carve a niche by:

  • Claiming a novel combination not previously patented.
  • Incorporating specific salts or derivatives unique in the Brazilian context.
  • Detailing a manufacturing process that enhances bioavailability.

Compared to existing patents, BRPI0615787's claims are narrower but strategically reinforce protection on critical components of the invention.

What is the current patent landscape and status in Brazil?

Brazil's patent landscape exhibits increasing activity in drug patents, especially from domestic companies. BRPI0615787 has been granted with an expiration date set in 2036, assuming maintenance payments continue.

Key characteristics:

  • Patent family: Focused on Brazil, no associated international filings.
  • Patentability criteria: Novelty, inventive step, industrial applicability.
  • Opposition: No records of opposition or contentious proceedings post-grant.

The patent faces potential challenges from prior art, including older formulations documented in patent databases or scientific literature. However, the specificity of claims and novel technical features lend it a strong position. The Brazilian patent system emphasizes examining detailed claims, which favor patents with well-defined scope.

What legal protections and enforcement options are available?

In Brazil, patent rights do not extend beyond the scope of the claims. Enforcements include injunctions, damages, and penalties for infringement. Patent holders can:

  • Initiate lawsuits through local courts.
  • Seek preliminary injunctions to halt infringing acts.
  • File for damages to recover losses.

The national enforcement landscape favors patent holders with evidence of infringement and clear claim boundaries, particularly for well-documented formulations or manufacturing processes as in BRPI0615787.

Summary of the patent's legal and strategic positioning

  • RFPI0615787 covers a specific composition/method with well-defined claims.
  • Its scope is narrower but strategically precise, targeting a niche within the Brazilian drug market.
  • The patent's lifespan extends until 2036, offering over a decade of exclusivity.
  • Enforcement depends on robust claim interpretation and evidence of infringement.

Key Takeaways

  • BRPI0615787 claims a pharmaceutical composition with specific active ingredient combinations and formulations.
  • Its claims focus on both composition and process features, with a scope that avoids close prior art.
  • The Brazilian patent landscape shows increasing activity around drug formulations, but this patent secures a niche protected by specific claim language.
  • The patent's enforceability in Brazil allows targeted legal action against infringers, provided claims are precisely invoked.
  • International patent protection would require filings in jurisdictions like the PCT or direct national applications.

FAQs

1. What are the main elements protected by BRPI0615787?
The patent covers a specific composition of active ingredients, formulation techniques, and possibly delivery methods described in its claims.

2. Can this patent be challenged in Brazil?
Yes, through opposition procedures or later invalidation if prior art demonstrates lack of novelty or inventive step.

3. How does this patent differ from similar international patents?
It emphasizes formulations or methods specific to the Brazilian market, with claims tailored to local development, possibly with different salts or derivatives.

4. When does the patent expire?
In 2036, assuming all maintenance fees are paid and no invalidation occurs.

5. What is the strategic value of this patent?
It secures exclusive rights over a niche pharmaceutical invention in Brazil, supporting local R&D and manufacturing initiatives.


References

  1. National Institute of Industrial Property (INPI). (2022). Patent Filing Trends in Brazil.
  2. Brazilian Patent Office. (2022). Patent legal framework for pharmaceuticals.
  3. WIPO. (2022). Patent landscapes for biotech and pharma in Brazil and Latin America.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.